Get the latest tech news
ITC Judge Rules Apple Watch Blood Oxygen Workaround Does Not Infringe Masimo Patents
Apple's current blood oxygen sensing implementation in the U.S. does not infringe on patents owned by Masimo and Apple will not face a revived import ban, a U.S. International Trade Commission judge said this week (via Reuters). After Apple was found to have violated Masimo's patents related to blood oxygen sensing, the Apple Watch faced a U.S. import ban that caused Apple to briefly pause sales of the device in December 2023 before Apple earned a temporary stay.
None
Or read this on Mac Rumors
